● FreshLatest: Aug 13, 2026

Regencell Bioscience Holdings Limited

RGC✓

HealthcareDrug Manufacturers - Specialty & GenericNASDAQ

● FreshLatest: Aug 13, 2026

$5.12+1.09%

$2.53BMarket cap

-356.34xP/E ratio

106.57KVolume (24h)

HealthcareDrug Manufacturers - Specialty & GenericNASDAQ

Earnings history

Consensus

Hold

4 analysts

Next earnings

Oct 28, 2026

Estimated report date

Firm	Action	Rating	Date
B. Riley	Downgrade	Buy -> Neutral	Jan 2, 2018
RBC Capital	Downgrade	Outperform -> Perform	Dec 6, 2017
Moffett Nathanson	Upgrade	Sell -> Neutral	Dec 6, 2017
Macquarie	Downgrade	Outperform -> Neutral	Dec 6, 2017

Analyst estimates are third-party opinions, not guarantees. For information only.